BioCentury | Nov 17, 2014
Clinical News

Flubok regulatory update

...infection in adults ages >=50 years. Flubok was approved in adults ages 18-49 years. The trivalent seasonal influenza vaccine...
...Korea Product: Flubok ( UMN-0502 , ASP7374 ) Business: Infectious Molecular target: Not available Description: Trivalent seasonal influenza vaccine...
BioCentury | Sep 8, 2014
Company News

Protein Sciences, Liomont deal

...countries. Protein Sciences declined to disclose terms, and Liomont could not be reached. Flublok, a trivalent seasonal influenza vaccine...
BioCentury | Jun 30, 2014
Company News

Protein Sciences, U.S. Department of Health and Human Services deal

...of the two option periods in February 2013 (see BioCentury, March 4, 2013). Flublok, a trivalent seasonal influenza vaccine...
BioCentury | Jun 9, 2014
Clinical News

Flubok regulatory update

...deal with UMN Pharma. Last year, FDA approved a BLA from Protein Sciences for the trivalent seasonal influenza vaccine...
BioCentury | Feb 10, 2014
Clinical News

Flublok: Phase III data

...Korea Product: Flublok ( UMN-0502 , ASP7374 ) Business: Infectious Molecular target: Not available Description: Trivalent seasonal influenza vaccine...
BioCentury | Feb 10, 2014
Clinical News

Flublok: Phase III data

...Korea Product: Flublok ( UMN-0502 , ASP7374 ) Business: Infectious Molecular target: Not available Description: Trivalent seasonal influenza vaccine...
BioCentury | Nov 4, 2013
Clinical News

ASP7374: Phase III ongoing

...Korea Product: ASP7374 ( Flublok , UMN-0502 ) Business: Infectious Molecular target: Not available Description: Trivalent seasonal influenza vaccine...
BioCentury | Nov 4, 2013
Clinical News

ASP7374: Phase III ongoing

...Korea Product: ASP7374 ( Flublok , UMN-0502 ) Business: Infectious Molecular target: Not available Description: Trivalent seasonal influenza vaccine...
BioCentury | Jul 1, 2013
Company News

AstraZeneca, GlaxoSmithKline, Sanofi infectious news

President Obama signed into law H.R. 475 to update the existing excise tax to include coverage of any vaccine against seasonal flu. The update now allows the excise tax to apply to quadrivalent seasonal influenza...
BioCentury | Jul 1, 2013
Clinical News

Flublok regulatory update

...seasonal influenza in adults ages 18-49 years (see BioCentury, Jan. 21). The product is a trivalent seasonal influenza vaccine...
Items per page:
1 - 10 of 34